XBRL SEC Pilot Pfizer Inc.

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, M3tHSHQR1f/T1G316Hd63Ti6uhZvzVxLufVEhEUZW+QVueXg6UWFdJ0+9xI1UOgV s36g0PEdHQfoUTYdZhQ1qA== 0000078003-07-000317.txt : 20071115 0000078003-07-000317.hdr.sgml : 20071115 20071115111636 ACCESSION NUMBER: 0000078003-07-000317 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 7 CONFORMED PERIOD OF REPORT: 20071115 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20071115 DATE AS OF CHANGE: 20071115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PFIZER INC CENTRAL INDEX KEY: 0000078003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 135315170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-03619 FILM NUMBER: 071248305 BUSINESS ADDRESS: STREET 1: 235 E 42ND ST CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2125732323 MAIL ADDRESS: STREET 1: 235 E 42ND ST CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: PFIZER CHARLES & CO INC DATE OF NAME CHANGE: 19710908 8-K 1 k8pfe20070930.htm XBRL PFIZER 8-K XBRL SEC Pilot Pfizer Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 15, 2007
PFIZER INC. (Exact name of registrant as specified in its charter)

DELAWARE (State or other jurisdiction of incorporation)	1-3619 (Commission File Number)	13-5315170 (I.R.S. Employer Identification No.)

235 East 42nd Street, New York, New York 10017 (Address of principal executive offices) (zip code) (212) 573-2323 (Registrant's telephone number)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions:

[ ] Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01. Other Events

Exhibit 100 to this Current Report on Form 8-K contains documents formatted in XBRL (eXtensible Business Reporting Language) with information from Pfizer Inc.'s Quarterly Report on Form 10-Q for the quarter ended September 30, 2007, filed with the Securities and Exchange Commission (SEC) on November 5, 2007. The information formatted in XBRL includes the (i) Condensed Consolidated Statements of Income for the three months and nine months ended September 30, 2007, and October 1, 2006, (ii) Condensed Consolidated Balance Sheets as of September 30, 2007, and at December 31, 2006, and (iii) Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2007 and October 1, 2006.

Users of this data are advised pursuant to Rule 401 of Regulation S-T that the financial information contained in the XBRL-Related Documents is unaudited and these are not the official financial statements of Pfizer Inc. as filed with the SEC. The purpose of furnishing these XBRL formatted documents is solely for the purpose of participation in the SEC's voluntary XBRL pilot program to test the related format and technology and, as a result, investors should continue to rely on the official filed version of the furnished documents and not rely on the information in this Current Report on Form 8-K, including Exhibit 100, in making investment decisions.

In accordance with Rule 402 of Regulation S-T, the information in this Current Report on Form 8-K, including Exhibit 100, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.

(d)	Exhibits

	The following exhibits are furnished herewith:

	Exhibit Number	Exhibit Description

	100	The following financial statements from Pfizer Inc.'s Quarterly Report on Form 10-Q for the quarter ended September 30, 2007, filed on November 5, 2007, formatted in XBRL (extensible Business Reporting Language): (i) the Condensed Consolidated Statements of Income for the three months and nine ended September 30, 2007, and October 1, 2006, (ii) the Condensed Consolidated Balance Sheets as of September 30, 2007, and December 31, 2006, and (iii) the Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2007 and October 1, 2006.

SIGNATURE

Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.


		PFIZER INC.

		By: /s/ Margaret M. Foran
		Margaret M. Foran


Dated: November 15, 2007		Title: Senior Vice President-Corporate Governance
		Associate General Counsel and Corporate Secretary

EXHIBIT INDEX

Exhibit No.		Description

EX-100.INS		XBRL Instance Document

EX-100.SCH		XBRL Taxonomy Extension Schema Document

EX-100.SCH.1		XBRL Schema Supplement Document

EX-100.CAL		XBRL Taxonomy Extension Calculation Linkbase Document

EX-100.LAB		XBRL Taxonomy Extension Label Linkbase Document

EX-100.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

EX-100.INS 2 pfe-20070930.xml XBRL INSTANCE DOCUMENT 0000078003 2006-10-01 unaudited 0000078003 2005-12-31 audited 0000078003 2007-07-02 2007-09-30 unaudited 0000078003 2007-01-01 2007-09-30 unaudited 0000078003 2006-07-03 2006-10-01 unaudited 0000078003 2006-01-01 2006-10-01 unaudited 0000078003 2007-09-30 unaudited 0000078003 2006-12-31 audited xbrli:shares iso4217:USD xbrli:shares iso4217:USD 1903000000 1628000000 2446000000 798000000 2372000000 774000000 62000000 115000000 0 2220000000 0.72 0.24 0.87 0.29 -491000000 -1180000000 353000000 123000000 -82000000 -35000000 0.05 0.02 -0.01 -0.01 0.05 0.02 -0.01 -0.01 2055000000 2000000 -788000000 -577000000 -201000000 -89000000 -37000000 139000000 23000000 3000000 -82000000 -35000000 9535000000 3239000000 5502000000 796000000 330000000 120000000 0 0 2031000000 4207000000 993000000 130000000 2000000 0 3892000000 4922000000 10000000 5000000 6000000 1000000 2138000000 4346000000 6510000000 7489000000 67000000 0 -958000000 -343000000 -1149000000 -260000000 -82000000 -268000000 2927000000 3415000000 0 5816000000 3157000000 3749000000 -11721000000 -744000000 229000000 173000000 17346000000 23426000000 22000000 21000000 -4496000000 -7494000000 -835000000 -1406000000 -118000000 -93000000 -1438000000 -1218000000 -8472000000 -16606000000 816000000 249000000 2318000000 455000000 2434000000 2645000000 514000000 526000000 593000000 537000000

9392000000

9942000000

2019000000

2298000000

-469000000

93000000

-1989000000

-464000000

69104000000

69832000000

114837000000

109030000000

1.36

0.47

0.78

0.11

2247000000

1177000000

1827000000

2611000000

579000000

465000000

441000000

442000000

5423000000

1962000000

8614000000

4618000000

21389000000

14328000000

-1333000000

-1969000000

8015000000

7544000000

1.35

0.46

0.78

0.11

-5211000000

-6021000000

-8000000

14000000

506000000

335000000

11314000000

3961000000

6308000000

636000000

1.3

0.44

0.79

0.12

1.31

0.45

0.79

0.12

6466000000

266000000

24350000000

20998000000

20876000000

21210000000

6111000000

5210000000

43479000000

42420000000

114837000000

109030000000

5546000000

6041000000

-18846000000

-12410000000

4666000000

3594000000

13118000000

9586000000

9888000000

3362000000

5420000000

761000000

-1070000000

784000000

180000000

343000000

35768000000

12280000000

35548000000

11990000000

1970000000

1957000000

3632000000

3319000000

141000000

103000000

1051000000

1243000000

3000000

29000000

513000000

283000000

16632000000

15714000000

1769000000

717000000

800000000

-161000000

-55000000

-61000000

5187000000

1902000000

5829000000

1999000000

49669000000

51063000000

11027000000

3751000000

10973000000

3768000000

25886000000

19687000000

71358000000

66610000000

46949000000

41840000000

4026000000

4084000000

-46740000000

-54346000000

7306000000

7251000000

6986000000

6894000000

7275000000

7228000000

6964000000

6875000000

513000000

283000000

(a) Exclusive of amortization of intangible assets, except as disclosed in Note 11B. Goodwill and Other Intangible Assets: Other Intangible Assets. EX-100.SCH 3 pfe-20070930.xsd XBRL EXTENSION TAXONOMY EX-100.SCH.1 4 pfe_ssu-xbrl.xsd XBRL SCHEMA SUPPLEMENT DOCUMENT EX-100.CAL 5 pfe-20070930_cal.xml XBRL CALCULATION LINKBASE EX-100.LAB 6 pfe-20070930_lab.xml XBRL LABEL LINKBASE Cost of sales Selling, informational and administrative expenses Other assets (including deposits and advances) deferred taxes and deferred charges Other assets, deferred taxes and deferred charges Prepaid Expenses - Total Prepaid Insurance Dividends payable represent dividends declared but not yet paid. Dividends payable Liabilities Discontinued Operations - Current Postretirement benefit obligations Accrued compensation and related items includes accrued employee compensation, accrued payroll taxes, accrued pension, accrued postemployment benefits, accrued postretirement benefits and other related items Accrued compensation and related items Represents the fair value of Pfizer Inc shares owned by the Trust used to fund Pfizer's employee benefit plans. Employee benefit trust, at fair value Income from continuing operations before (benefit)/provision for taxes on income and minority interests Income from discontinued operations-net of tax Income/(loss) from businesses or product lines that have been discontinued net of tax. Income/(Loss) from Disposition of Discontinued Operations - Total Cash dividends paid per common share cash dividends paid per common share Consists of other current liabilities and deferred income tax liabilities current. Other current liabilities Other (income)/deductions-net Other (income)/deductions-net can include non operating items such as interest income/expense, royalty income, asset impairments, gains/losses on sale of fixed assets, gains/losses on disposals of investments or products. income from continuing operations after provision for taxes and minority interest Income from continuing operations Net cash provided by operating activities cash payments for purchases of property, plant and equipment Purchases of property, plant and equipment Proceeds from redemptions of short-term investments Proceeds from redemptions of long-term investments Purchases of long-term investments Acquisitions, net of cash acquired Net cash provided by investing activities Cash provided by/(used in) other investing activities, net. Other investing activities Share-based compensation expense Acquisition-related in-process research and development charges Asset impairment charge Other non-cash adjustments Deferred taxes from continuing operations Proceeds from the sales of businesses, products and product lines Proceeds from Short-Term Borrowings Principal payments on short-term borrowings Proceeds from issuances of long-term debt Principal payments on long-term debt Purchases of common stock Cash dividends paid cash received from stock option exercises and other financing related cash transactions not previously identified Stock option transactions and other Net cash used in financing activities Effect of exchange-rate changes on cash and cash equivalents Cash and cash equivalents at beginning of period cash paid for income taxes Cash paid during the period for income taxes Cash paid during the period for interest amortization of intangible assets Amortization of intangible assets subsidiary income not owned by the consolidating entity, net of taxes Minority interests total of operations and gains/(losses) on sales of discontinued operations net of tax. Discontinued operations-net of tax Revenues Research and development expenses Acquisition-related in-process research and development charges (Benefit)/provision for taxes on income Income/(Loss) from Disposition of Discontinued Operations Gain/(loss) on disposal of discontinued operations net of tax Gains/(losses) on sales of discontinued operations - net of tax Income from continuing operations per common share-basic Income/(Loss) from Discontinued Operations per Outstanding Share Net income per common share-basic Weighted-average shares used to calculate earnings per common share-basic Income/(loss) from Disposition of Discontinued Operations per Outstanding Share Net income per common share-diluted Weighted-average shares used to calculate earnings per common share-diluted Income from continuing operations per common share-diluted Cash and cash equivalents Accounts receivable, less allowance for doubtful accounts Short-term investments Inventories Assets Discontinued Operations-Current Total current assets Property, plant and equipment, less accumulated depreciation Identifiable intangible assets, less accumulated amortization Total assets Accounts payable Income taxes payable Total current liabilities Long-term debt Pension benefit obligations Deferred taxes Other noncurrent liabilities Total liabilities Preferred stock Common stock Additional paid-in capital Treasury stock Retained earnings Accumulated other comprehensive income/(expense) Total shareholders' equity Total liabilities and shareholders' equity Purchases of short-term investments Proceeds from sales of other assets Net increase/(decrease) in cash and cash equivalents Depreciation and amortization Purchases of other assets Cash and cash equivalents at end of period Income/(loss) from discontinued operations net of tax per common share basic Discontinued operations - net of tax per common share-basic Income/(loss) from discontinued operations net of tax per common share diluted Discontinued operations - net of tax per common share-diluted Assets held for sale Liabilities held for sale and anticipated to be sold within 12 months. Liabilities held for sale Consists of assets of discontinued operations and long-lived assets held for sale that are expected to be disposed of or have been disposed of at the financial statement date. Assets held for sale Net income Long-term investments and loans consists of (a) investments in nonconsolidated subsidiaries accounted for using the equity and or cost method; (b) debt and equity financial instruments which can include trading securities, held-to-maturity and securities available for sale; (c) long-terms loans with maturities in excess of one year. The portion of long-term loans that is due to be collected within one year is recorded under Short-term loans Long-term investments and loans Short-term borrowings have maturities within 12 months, including portion of long-term debt with maturities within 12 months Short-term borrowings, including current portion of long-term debt Consists of liabilities of discontinued operations and other liabilities held for sale that are expected to be disposed of or have been disposed of at the financial statement date. Liabilities held for sale Short-term loans are those with an original maturity of one year or less. Also included in this account is the portion of long-term loans that are due to be collected within one year. Short-term loans Includes Prepaid expenses and current deferred tax asset. Prepaid expenses are the unamortized costs of rights to receive a service or use a resource. These prepayments include, for example, employee advances, prepaid insurance, prepaid taxes, etc Prepaid expenses and taxes Includes minority interest and other noncurrent liabilities. Other noncurrent liabilities Gains on disposal of investments, products and product lines Gains on disposal of investments, products and product lines Non-cash gains from sales of businesses or product lines that have been discontinued. (Gains)/losses on sales of discontinued operations Noncash deferred taxes related to discontinued operations Other deferred taxes Non cash charges for intangible asset impairments and associated non-cash charges Intangible asset impairments and other associated non-cash charges Changes in assets and liabilities (net of businesses acquired and divested) from beginning to end of period. Changes in assets and liabilities (net of businesses acquired and divested) Nonoperating Income/(Expense) Income before cumulative effect of a change in accounting principles Cumulative effect of a change in accounting principles - net of tax Income before cumulative effect of a change in accounting principles per common share-basic Cumulative effect of a change in accounting principles per common share-basic Income before cumulative effect of a change in accounting principles per common share-diluted Cumulative effect of a change in accounting principles per common share-diluted Accounts receivable Inventories Change in prepaid and other assets Prepaid and other assets Accounts payable and accrued liabilities Income taxes payable Change from beginning to end of period in other liabilities included in operating activities not separately defined. Other liabilities The same definition as net cash provided by operating activities except only from continuing operating activities Net cash provided by continuing operating activities Non-cash addback to net income for fair value mark-up of acquired inventory sold. Charge for fair value mark-up of acquired inventory sold Cash and cash equivalents acquired through acquisition of Pharmacia. Cash and cash equivalents acquired through acquisition of Pharmacia Cash purchases of other assets Purchases of other assets Acquisition of Pharmacia, net of transaction costs Allowance for doubtful accounts Current portion of long-term debt The noncash impact on net income resulting from a change in accounting principle Cumulative effect of a change in accounting principles (Preferred stock) Preferred Stock Restructuring charges are associated with the exit or disposal of an activity, including one-time termination benefits, contract termination costs and other exit costs (e.g., consolidation of facilities). Acquisition-related costs consist of integration costs directly related to acquisitions and restructuring costs incurred in connection with acquisitions. Restructuring charges and acquisition-related costs Represents portion of proceeds received in the form of short-term investments from the sale of the Consumer Healthcare business. Sale of the Consumer Healthcare business Increase/(Decrease) in Employee Benefit Trust Employee benefit trust Beginning balance of employee benefit trust-value Employee Benefit Trust - Beginning Balance - Value Ending balance of employee benefit trust-value Employee Benefit trust - Ending Balance - Value Beginning balance of employee benefit trust - shares Employee Benefit Trust - Beginning Balance Shares Ending balance of employee benefit trust shares Employee Benefit Trust - Ending Balance Shares Employee benefit trust transactions - net - Additional Paid in Capital Purchases of common stock above par value for employee trusts. The impact on additional paid-in capital from preferred stock conversions and redemptions. Preferred stock conversions and redemptions - Additional Paid in Capital Comprehensive income is the total of net income and other comprehensive income (which can include currency translation adjustments; net unrealized gains and losses on derivative financial instruments and available for sale securities; and amounts related to benefit plans for actuarial losses, prior service costs and minimum pension liability). Total comprehensive income The net change in the total of preferred shares during an accounting period resulting from conversions and redemptions. Preferred stock conversions and redemptions Preferred stock conversions and redemptions Treasury stock used in connection with employee trusts. Employee benefit trust transactions-net-shares Treasury stock acquired for stock option transactions. Stock option transactions-shares The impact on accumulated other comprehensive income/(expense) resulting from the adoption of a new accounting standard Adoption of new accounting standard-net of tax The total net change in the cumulative amount for comprehensive income/(expense) other than net income (loss) during an accounting period. It can include net changes in foreign currency translation adjustment, unrealized holding gains/(losses) on securities adjusted for any reclassified realized gains/(losses) and amounts related to benefit plans for actuarial losses, prior service costs and minimum pension liability. Total other comprehensive income (expense)-net of tax The total of net income and total other comprehensive income-net of tax during an accounting period. Total comprehensive income Employee trusts are trusts that hold Pfizer stock for employees which are used to fund future obligations under Pfizer benefit and compensation plans. Employee benefit trust transactions-net The net change in the total value of preferred stock during an accounting period; may result from new issuance, repurchase, converison of convertible preferred stocks, etc. Preferred stock conversions and redemptions The impact on shareholders' equity resulting from the adoption of a new accounting standard. Adoption of new accounting standard-net of tax The change in value of employee benefit trust resulting from stock option transactions during an accounting period. Stock option transactions The net change in value of employee benefit trust resulting from employee benefit transactions during an accounting period. Employee benefit trust transactions-net The change in shares of employee benefit trust resulting from stock option transactions during an accounting period. Stock option transactions-Shares The change in shares of the employee benfit trust resulting from employee benefit transactions during an accounting period Employee benefit trust transactions-net-Shares Preferred stock Common stock Treasury stock Amount of long-term debt due within one year. Current portion of long-term debt Preferred Stock - Description Stock option transactions Stock option transactions - shares Purchases of common stock Stock option transactions Purchases of common stock-shares Stock option transactions Total other comprehensive income-net of tax Stock option transactions Purchases of common stock Preferred Stock - Shares Authorized Preferred Stock - Shares Issued (preferred stock 2006) Preferred Stock Accumulated Other Comprehensive Income (Expense)- Beginning Balance Cash dividends declared - Preferred Stock Cash dividends declared - Common Stock Cash dividends declared and or paid by an entity to common shareholders Cash dividends declared-Common Stock Cash dividends declared and or paid by an entity to preferred shareholders Cash dividends declared-Preferred Stock Accumulated Other Comprehensive Income (Expense) - Ending Balance The value of treasury shares used to source the preferred stock in-kind (shares) conversions. Preferred stock conversions and redemptions The amount of treasury shares used to source the preferred stock in-kind (shares) conversions. Preferred stock conversions and redemptions Cash proceeds from the sales of businesses, products and product lines. Proceeds from the sales of businesses, products and product lines The effect of switching from one accounting method to another net of tax. Cumulative effect of a change in accounting principles-net of tax The net of new short-term borrowings with maturities of 90 days or less and new repayments of short-term borrowings with maturities of 90 days or less, and new short-term borrowings with maturities greater than 90 days. Increase in short-term borrowings, net Other changes in the number of shares of comon stock. Other Cash outflows for purchases of short-term investments. Purchases of short-term investments Proceeds from redemptions of short-term investments Cash inflows from the redemptions of short-term investments. The net change in the cumulative amount for comprehensive income other than the net income (loss) during an accounting period; including net changes in foreign currency translation adjustment; in unrealized holding gains(losses) on securities adjusted for any reclassified realized gains (losses); and in amounts related to benefit plans for actuarial losses, prior service costs and minimum pension liability. Total other comprehensive income (expense) net of tax Other - Additional Paid in Capital Other - Treasury Stock Value Payments to repurchase common stock. Purchases of common stock Cash outflows for principal repayments of short-term borrowings Principal payments on short-term borrowings Cash inflows from the redemptions of long-term investments. Proceeds from redemptions of long-term investments Cash outflows for the purchases of long-term investments. Purchases of long-term investments Other Increase/(Decrease) in Stockholders' Equity Other - Treasury Stock - Shares Other - Common Stock Value (Excluding Additional Paid in Capital) The change in treasury shares for activities not separately identified. Other Treasury Stock - shares Other taxes payable in connection with the adoption of FIN 48. Other taxes payable (income)/loss from operations of businesses or product lines that have been discontinued. Income from discontinued operations EX-100.PRE 7 pfe-20070930_pre.xml XBRL PRESENTATION LINKBASE -----END PRIVACY-ENHANCED MESSAGE-----